Catherine L Wall
Overview
Explore the profile of Catherine L Wall including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
180
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wall C, Bensley R, Glyn T, Haines M, Rowbotham D, Bissett I, et al.
Nutrients
. 2024 Jul;
16(13).
PMID: 38999853
Preoperative exclusive enteral nutrition (EEN) improves nutritional status, reduces intestinal inflammation, and likely improves surgical outcomes. Crohn's disease exclusion diet with partial enteral nutrition (CDED) also reduces intestinal inflammation but...
2.
Diep-Pham H, Donald N, Wall C
Nutr Diet
. 2023 Aug;
80(5):530-537.
PMID: 37614059
Aims: This research aimed to assess the rate and reliability of routine nurse-completed malnutrition screening and report the prevalence of malnutrition risk on admission to Christchurch Hospital. Methods: Student dietitians...
3.
Brown S, Wall C, Gearry R, Day A
Pediatr Gastroenterol Hepatol Nutr
. 2023 May;
26(3):165-172.
PMID: 37214167
Crohn's disease (CD) is a chronic, incurable and relapsing disease involving any part of the gastrointestinal tract and exclusive enteral nutrition (EEN) is first-line therapy. Few studies have examined the...
4.
McCarthy N, Schultz M, Wall C
Nutr Diet
. 2023 Apr;
80(5):538-545.
PMID: 37056216
Aim: Nutritional therapies for inflammatory bowel disease are increasingly recommended. This study aimed to gain insight from patients, dietitians and gastroenterologists into inflammatory bowel disease dietetic care in New Zealand....
5.
Speedy A, Wall C
Aliment Pharmacol Ther
. 2023 Mar;
57(8):907-908.
PMID: 36952271
No abstract available.
6.
MacIntosh A, Heenan P, Wright-McNaughton M, Frampton C, Skidmore P, Wall C, et al.
Front Nutr
. 2023 Feb;
10:1060928.
PMID: 36819701
Background And Aims: A low fermentable oligosaccharide, disaccharide, monosaccharide, and polyols (FODMAP) diet alleviates symptoms of irritable bowel syndrome (IBS). We aimed to investigate the relationship between habitual FODMAP intake...
7.
Wall C, Wilson B, Lomer M
Front Nutr
. 2023 Feb;
10:1065592.
PMID: 36819688
Background And Aim: The identification of, and timely intervention for, patients with impaired nutritional status may reduce inflammatory bowel disease (IBD) complications. This study aimed to develop and validate an...
8.
Godny L, Svolos V, Williams A, Czuber-Dochan W, Aloi M, Ibarra A, et al.
J Crohns Colitis
. 2022 Dec;
17(5):663-680.
PMID: 36541887
Background And Aims: Patients with inflammatory bowel disease [IBD] are often affected during their reproductive years and may have many perinatal queries that require the comprehensive perspectives of a multidisciplinary...
9.
Cox S, Czuber-Dochan W, Wall C, Clarke H, Drysdale C, Lomer M, et al.
Nutrients
. 2022 Oct;
14(20).
PMID: 36296976
Food-related quality of life (FR-QoL) is impaired in inflammatory bowel disease (IBD) and education and support on food-related issues in IBD is needed. This feasibility trial aimed to investigate the...
10.
Bayer S, Heenan P, Frampton C, Wall C, Drummond L, Roy N, et al.
Nutrients
. 2022 Oct;
14(19).
PMID: 36235798
Chronic constipation is highly prevalent worldwide and may be managed with two green or three gold kiwifruit daily. It is unknown whether a smaller standard serve of gold kiwifruit (two...